Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Laus

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Thoracic Cancer|September 4, 2020
EGF+61 A>G polymorphism does not predict response to first-generation EGFR tyrosine kinase inhibitors in lung cancer patientsLeticia F Leal, Ana C Laus, Rodrigo Cavagna, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 21, 2024
Novel high-yield potato protease inhibitor panels block a wide array of proteases involved in viral infection and crucial tissue damageNienke Visser, Laure C M Herreman, Jennifer Vandooren, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Thoracic Cancer|September 4, 2020
EGF+61 A>G polymorphism does not predict response to first-generation EGFR tyrosine kinase inhibitors in lung cancer patientsLeticia F Leal, Ana C Laus, Rodrigo Cavagna, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 21, 2024
Novel high-yield potato protease inhibitor panels block a wide array of proteases involved in viral infection and crucial tissue damageNienke Visser, Laure C M Herreman, Jennifer Vandooren, et al.
Pageof 3